Skip to main content

Month: August 2020

Comstock Mining Announces Full Second Quarter 2020 Results; Increased Strategic Investment Values Drives Positive Net Income, Deploying Mercury Systems

VIRGINIA CITY, Nev., Aug. 17, 2020 (GLOBE NEWSWIRE) — Comstock Mining Inc. (the “Company”) (NYSE American: LODE) filed its Quarterly Report on Form 10-Q last week and announced selected strategic and financial results for the fiscal quarter ended June 30, 2020, including the arrival and assembly of our first mercury remediation system.Recent 2020 Selected Strategic Highlights Extinguished the current Senior Secured Debenture from a combination of $0.9 million in accelerated cash proceeds from Tonogold and new, unsecured promissory notes, with favorable, extended terms;Investments in Tonogold Resources Inc. (“Tonogold”) valued at $10.4 million at June 30, 2020, a $1.6 million increase in fair market value driving positive net income for the three months ended June 30, 2020; Investment in Mercury Clean Up LLC (“MCU”) increased to...

Continue reading

Brown & Brown, Inc. Announces the Asset Acquisition of Amity Insurance Agency

DAYTONA BEACH, Fla., Aug. 17, 2020 (GLOBE NEWSWIRE) — J. Scott Penny, Chief Acquisitions Officer of Brown & Brown, Inc. (NYSE:BRO), and Justin T. Kesner and Jonathan A. Lanza, the principals of Amity Insurance Agency, Inc., today announced that Brown & Brown of Massachusetts, Inc., a subsidiary of Brown & Brown, Inc., has acquired substantially all of the assets of Amity Insurance Agency.Amity Insurance was founded in 1978 and offers a wide spectrum of insurance products and services, specializing in risk management solutions for customers in the legal, parking, transportation, and construction industries. The firm also provides a variety of personal lines insurance products and services to individuals throughout New England. Following the transaction, the Amity team will continue operating from their existing office...

Continue reading

Port of Halifax Enhances Business Development Efforts for Containerized Cargo Operations with Descartes Datamyne

WATERLOO, Ontario, Aug. 17, 2020 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that the Port of Halifax is enhancing its business development efforts for containerized shipping operations by using Descartes Datamyne™ to access detailed import/export data in its prospective trade lanes.“Our goal is to make Halifax the east coast choice for cargo arriving from central Canada and the midwestern U.S. by demonstrating to importers, cargo owners, freight forwarders, terminals and rail providers how the port can fit into their supply chain,” said Rob McInnes, Manager of Business Development at Halifax Port Authority. “We are a long-time subscriber to Descartes Datamyne and continue to find it invaluable, especially the in-depth information...

Continue reading

UCLOUDLINK GROUP INC. Announces Unaudited Second Quarter 2020 Financial Results

HONG KONG, Aug. 17, 2020 (GLOBE NEWSWIRE) — UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced its unaudited financial results for the three months ended June 30, 2020.Financial Highlights for the Second Quarter of 2020Total revenues were US$21.0 million, representing a decrease of 41.5% from US$35.9 million in the second quarter of 2019.Gross profit was US$5.5 million, representing a decrease of 63.8% from US$15.2 million in the second quarter of 2019. Loss from operations was US$41.5 million, compared with income from operations US$0.2 million in the second quarter of 2019.Net loss was US$41.6 million, compared with net income of US$0.3 million in the second quarter of 2019.Adjusted net loss (non-GAAP) was US$4.8 million, compared...

Continue reading

TOMI’s CEO Comments on Share Price

BEVERLY HILLS, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQB:TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products – a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP).Dr. Halden Shane, TOMI’s CEO, states, “There have been many inquiries about our stock price decline despite the company delivering record earnings.  As stated on the earnings call there is no fundamental reason for the decline. It would appear that the stock price on Thursday and Friday may be attributed to certain investors who misinterpreted comments on our prior earnings call on May 18th, 2020 as we do not give formal guidance, but we do share good news on a real...

Continue reading

CytoDyn Will Attempt to Duplicate Berlin and London Patients’ HIV Cure by Using Leronlimab During Bone Marrow Transplant for 5 HIV Patients Who also have Cancer

HIV monotherapy trials update: 215 patients completed almost one year of monotherapy. Only some were allowed to continue in extension arm; five patients reached almost 6 years. Twenty-five reached 2 to 4 years and 20 patients are 1 to 2 yearsVANCOUVER, Washington, Aug. 17, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company gives full update on all of its HIV programs.HIV CureThe HIV co-receptor CCR5 has proven to be a key molecule in mediating HIV remission. The only two individuals functionally cured of HIV, one from London and the other from Berlin, received allogeneic stem cell transplantations from CCR5-deficient donors. However, because it is extremely rare to find a stem cell donor who lacks CCR5 and meets stringent MHC matching criteria, such an approach...

Continue reading

Delta 9 Reports Financials for Q2 2020

WINNIPEG, Manitoba, Aug. 17, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce financial and operating results for the three-month and six-month period ending June 30, 2020.Financial Highlights for the three-month period ending June 30, 2020Net revenue of $13.0 million for the second quarter of 2020, an increase of 46%, from $8.9 million for the same quarter last year.Sequential net revenue increased 11% versus $11.8 million for the three-month period ending March 31, 2020Gross profit of $4.6 million for the second quarter of 2020, an increase of 57%, from $2.9 million for the same quarter last year.Net income from operations of $1.7 million for the second quarter of 2020 versus a loss from operations of ($1.1 million) for the same quarter last year.Adjusted...

Continue reading

Demand for SteraMist BIT Solution Continues to Surge

BEVERLY HILLS, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQB:TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products – a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). We are continuing to see a substantial increase in purchases of SteraMist BIT solution since the beginning of 2020.SteraMist BIT Solution sales are a cornerstone of TOMI’s revenue stream as a source of recurring income from existing SteraMist product owners. BIT Solution is consistently being blended without delay to match the growing demand and ensure immediate shipment to our customers. Growing demand for SteraMist equipment and increasing service jobs contributing...

Continue reading

G1 Therapeutics Announces Acceptance and Priority Review of NDA for Trilaciclib for Patients with Small Cell Lung Cancer

– PDUFA action date of February 15, 2021 assigned by U.S. Food and Drug Administration– Priority Review for trilaciclib is based on positive data from three randomized clinical trials showing robust myelopreservation benefits– G1 launching expanded access program (EAP) for patients with small cell lung cancer in the U.S.RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for trilaciclib for small cell lung cancer (SCLC) patients being treated with chemotherapy and granted Priority Review with a Prescription Drug User Fee Act (PDUFA) action date of February 15, 2021. Trilaciclib is a first-in-class investigational therapy...

Continue reading

Evli launches its first green corporate bond fund

EVLI BANK PLC PRESS RELEASE AUGUST 17, 2020 AT 1.00 PM. (EET/EEST)Evli has launched its first fund which focuses on investing in green corporate bonds – the Evli Green Corporate Bond fund. The fund invests in green and sustainable bonds. Introduced by Evli’s distinguished fixed income team, with its successful track record of over 20 years in European credit.The fund is managed by Juhamatti Pukka, Head of Fixed Income at Evli and manager of the Evli Short Corporate Bond fund. Noora Lakkonen, Analyst at Evli’s Responsible Investment team and in charge of monitoring ESG factors for Evli’s corporate bond strategies, is responsible for the green bond analysis of the new fund.The Evli Green Corporate Bond fund is a natural progression for Evli, given its significant advances in integrating ESG factors into all areas of portfolio management....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.